CD79A and necrotizing enterocolitis: Clinical studies using oral administration of a plasma-derived and IgA-enriched IgG preparation, IgAbulin, has revealed promising results in children with chronic diarrhea (84), but mixed results in necrotizing enterocolitis (NEC), a life-threatening disorder primarily of preterm infants (27, 85).